Repurposing Colchicine to Combat Residual Cardiovascular Risk: The LoDoCo2 Trial

European Journal of Clinical Investigation ◽

10.1111/eci.13424 ◽

2020 ◽

Vol 50 (12) ◽

Author(s):

Simon Kraler ◽

Florian A. Wenzl ◽

Thomas F. Lüscher

Keyword(s):

Cardiovascular Risk ◽

Residual Cardiovascular Risk

Download Full-text

Residual cardiovascular risk in patients with dyslipidemia receiving multifactorial cardiovascular prevention therapy

Atherosclerosis ◽

10.1016/j.atherosclerosis.2021.06.451 ◽

2021 ◽

Vol 331 ◽

pp. e150

Author(s):

F. Barkas ◽

G. Anastasiou ◽

G. Liamis ◽

I. Gartzonikas ◽

H. Milionis ◽

...

Keyword(s):

Cardiovascular Risk ◽

Cardiovascular Prevention ◽

Residual Cardiovascular Risk ◽

Prevention Therapy

Download Full-text

Residual Cardiovascular Risk in Chronic Kidney Disease: Role of High-density Lipoprotein

Archives of Medical Research ◽

10.1016/j.arcmed.2015.05.009 ◽

2015 ◽

Vol 46 (5) ◽

pp. 379-391 ◽

Author(s):

Valentina Kon ◽

Haichun Yang ◽

Sergio Fazio

Keyword(s):

Chronic Kidney Disease ◽

Cardiovascular Risk ◽

Kidney Disease ◽

High Density Lipoprotein ◽

Density Lipoprotein ◽

High Density ◽

Residual Cardiovascular Risk

Download Full-text

Residual cardiovascular risk among people with diabetes

Diabetes Obesity and Metabolism ◽

10.1111/dom.13646 ◽

2019 ◽

Vol 21 (S1) ◽

pp. 28-38 ◽

Author(s):

Satya Dash ◽

Lawrence A. Leiter

Keyword(s):

Cardiovascular Risk ◽

Residual Cardiovascular Risk

Download Full-text

Non-invasive detection of coronary inflammation using computed tomography and prediction of residual cardiovascular risk (the CRISP CT study): a post-hoc analysis of prospective outcome data

10.1016/s0140-6736(18)31114-0 ◽

2018 ◽

Vol 392 (10151) ◽

pp. 929-939 ◽

Author(s):

Evangelos K Oikonomou ◽

Mohamed Marwan ◽

Milind Y Desai ◽

Jennifer Mancio ◽

Alaa Alashi ◽

...

Keyword(s):

Computed Tomography ◽

Cardiovascular Risk ◽

Outcome Data ◽

Residual Cardiovascular Risk ◽

Post Hoc Analysis ◽

Non Invasive ◽

Download Full-text

The soluble receptor for advanced glycation end-products (sRAGE) has a dual phase-dependent association with residual cardiovascular risk after an acute coronary event

Atherosclerosis ◽

10.1016/j.atherosclerosis.2019.05.020 ◽

2019 ◽

Vol 287 ◽

pp. 16-23 ◽

Author(s):

Helena Grauen Larsen ◽

Troels Yndigegn ◽

Goran Marinkovic ◽

Helena Grufman ◽

Razvan Mares ◽

...

Keyword(s):

Cardiovascular Risk ◽

Advanced Glycation End Products ◽

Coronary Event ◽

Acute Coronary Event ◽

Soluble Receptor ◽

Advanced Glycation ◽

Residual Cardiovascular Risk ◽

Glycation End Products ◽

Download Full-text

Residual cardiovascular risk and practical management of type 2 diabetes

The British Journal of Diabetes ◽

10.1177/1474651406006002s0501 ◽

2006 ◽

Vol 6 (2_suppl) ◽

pp. S17-S23

Author(s):

Miles Fisher ◽

Ian W Campbell

Keyword(s):

Type 2 Diabetes ◽

Cardiovascular Risk ◽

Residual Cardiovascular Risk ◽

Practical Management

Download Full-text

Icosapent ethyl: drug profile and evidence of reduced residual cardiovascular risk in patients with statin-managed LDL-C cholesterol

Expert Review of Cardiovascular Therapy ◽

10.1080/14779072.2020.1749596 ◽

2020 ◽

Vol 18 (4) ◽

pp. 175-180

Author(s):

Najdat Bazarbashi ◽

Michael Miller

Keyword(s):

Cardiovascular Risk ◽

Residual Cardiovascular Risk ◽

Drug Profile ◽

Icosapent Ethyl

Download Full-text

Reduction of LDL-C-related residual cardiovascular risk with ezetimibe: are mechanistic considerations warranted in practice?

European Heart Journal ◽

10.1093/eurheartj/ehx275 ◽

2017 ◽

Vol 38 (29) ◽

pp. 2276-2278 ◽

Author(s):

Karin H. Humphries ◽

G.B. John Mancini

Keyword(s):

Cardiovascular Risk ◽

Residual Cardiovascular Risk

Download Full-text

Update on the Discovery and Development of Cholesteryl Ester Transfer Protein Inhibitors for Reducing Residual Cardiovascular Risk

Journal of Medicinal Chemistry ◽

10.1021/jm400574e ◽

2013 ◽

Vol 57 (1) ◽

pp. 1-17 ◽

Author(s):

Nathan B. Mantlo ◽

Ana Escribano

Keyword(s):

Cardiovascular Risk ◽

Cholesteryl Ester ◽

Cholesteryl Ester Transfer Protein ◽

Protein Inhibitors ◽

Residual Cardiovascular Risk ◽

Transfer Protein

Download Full-text

Individualized lipid-lowering therapy to further reduce residual cardiovascular risk

The Journal of Steroid Biochemistry and Molecular Biology ◽

10.1016/j.jsbmb.2016.05.016 ◽

2017 ◽

Vol 169 ◽

pp. 198-201 ◽

Author(s):

Oliver Weingärtner ◽

Dieter Lütjohann ◽

Torsten Plösch ◽

Albrecht Elsässer

Keyword(s):

Cardiovascular Risk ◽

Lipid Lowering ◽

Lipid Lowering Therapy ◽

Residual Cardiovascular Risk ◽

Lowering Therapy

Download Full-text